bay x 1005 has been researched along with Asthma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dahlén, B; Dahlén, SE; Ihre, E; Kumlin, M; Zetterström, O | 1 |
| Hamilton, AL; O'Byrne, PM; Watson, RM; Wyile, G | 1 |
| Fischer, AR; Israel, E; Jungerwirth, S; Loper, M; Rosenberg, MA; Roth, M | 1 |
| Holgate, S; Sampson, A | 1 |
3 trial(s) available for bay x 1005 and Asthma
| Article | Year |
|---|---|
Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYx 1005.
Topics: Adult; Area Under Curve; Asthma; Bronchial Provocation Tests; Cross-Over Studies; Double-Blind Method; Forced Expiratory Volume; Humans; Leukotriene E4; Lipoxygenase Inhibitors; Male; Middle Aged; Quinolines | 1997 |
Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005.
Topics: Adult; Area Under Curve; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Cross-Over Studies; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Lipoxygenase Inhibitors; Male; Methacholine Chloride; Quinolines | 1997 |
Effect of a novel 5-lipoxygenase activating protein inhibitor, BAYx 1005, on asthma induced by cold dry air.
Topics: Adolescent; Adult; Analysis of Variance; Asthma; Bronchial Provocation Tests; Calcimycin; Cold Temperature; Cross-Over Studies; Double-Blind Method; Humans; Ionophores; Leukotriene B4; Lipoxygenase Inhibitors; Middle Aged; Quinolines | 1997 |
1 other study(ies) available for bay x 1005 and Asthma
| Article | Year |
|---|---|
Leukotriene modifiers in the treatment of asthma. Look promising across the board of asthma severity.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Asthma; Chromones; Humans; Leukotriene Antagonists; Lipoxygenase Inhibitors; Quinolines | 1998 |